Minerva Neurosciences, Inc. (NERV)
2.56
+0.07
(+2.81%)
USD |
NASDAQ |
Nov 11, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
Minerva Neurosciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2020 | 71.72% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | -14.20% |
| Tonix Pharmaceuticals Holding Corp. | -309.4% |
| Karyopharm Therapeutics, Inc. | -200.5% |
| Corbus Pharmaceuticals Holdings, Inc. | -- |
| Ocugen, Inc. | -184.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -351.7% |
| Return on Net Operating Assets | -1.96K% |